These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review. Lădaru A; Bălănescu P; Stan M; Codreanu I; Anca IA Biomarkers; 2016; 21(2):102-14. PubMed ID: 26632636 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review. Nicolaou O; Kousios A; Hadjisavvas A; Lauwerys B; Sokratous K; Kyriacou K J Cell Mol Med; 2017 May; 21(5):993-1012. PubMed ID: 27878954 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches. Chairta P; Nicolaou P; Sokratous K; Galant C; Houssiau F; Oulas A; Spyrou GM; Alarcon-Riquelme ME; Lauwerys BR; Christodoulou K Arthritis Res Ther; 2020 May; 22(1):107. PubMed ID: 32381114 [TBL] [Abstract][Full Text] [Related]
7. Circulatory cytokeratin 17, marginal zone B1 protein and leucine-rich α2-glycoprotein-1 as biomarkers for disease severity and fibrosis in systemic sclerosis patients. Bălănescu P; Bălănescu E; Băicuș C; Bălănescu A Biochem Med (Zagreb); 2022 Oct; 32(3):030707. PubMed ID: 36277429 [TBL] [Abstract][Full Text] [Related]
8. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review. Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048 [TBL] [Abstract][Full Text] [Related]
10. Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis. Chairta PP; Nicolaou P; Christodoulou K Sci Rep; 2023 Feb; 13(1):1934. PubMed ID: 36732374 [TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype. van Bon L; Cossu M; Loof A; Gohar F; Wittkowski H; Vonk M; Roth J; van den Berg W; van Heerde W; Broen JC; Radstake TR Ann Rheum Dis; 2014 Aug; 73(8):1585-9. PubMed ID: 24718960 [TBL] [Abstract][Full Text] [Related]
13. An update on biomarker discovery and use in systemic sclerosis. Matsushita T; Takehara K Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919 [TBL] [Abstract][Full Text] [Related]
15. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis. Bussone G; Dib H; Tamby MC; Broussard C; Federici C; Woimant G; Camoin L; Guillevin L; Mouthon L Arthritis Res Ther; 2011 May; 13(3):R74. PubMed ID: 21569507 [TBL] [Abstract][Full Text] [Related]
16. Targeted and Untargeted Proteomics Approaches in Biomarker Development. Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135 [TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers. Landi C; Bargagli E; Carleo A; Refini RM; Bennett D; Bianchi L; Cillis G; Prasse A; Bini L; Rottoli P Rheumatology (Oxford); 2019 Jan; 58(1):165-178. PubMed ID: 30239835 [TBL] [Abstract][Full Text] [Related]
18. Systematic approach to understanding the pathogenesis of systemic sclerosis. Zuo X; Zhang L; Luo H; Li Y; Zhu H Clin Genet; 2017 Oct; 92(4):365-371. PubMed ID: 27918067 [TBL] [Abstract][Full Text] [Related]
19. Circulating Reticulocalbin 1 and Reticulocalbin 3 in Systemic Sclerosis Patients: Results of a Case Control Study. Bălănescu P; Lădaru A; Bălănescu E; Pompilian V; Gologanu D; Caraiola S; Băicuş C; Dan GA Clin Lab; 2016; 62(6):1109-16. PubMed ID: 27468573 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers in the management of scleroderma: an update. Abignano G; Buch M; Emery P; Del Galdo F Curr Rheumatol Rep; 2011 Feb; 13(1):4-12. PubMed ID: 21046295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]